177 related articles for article (PubMed ID: 30759879)
1. Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation.
McGrath JA; O'Sullivan A; Bennett G; O'Toole C; Joyce M; Byrne MA; MacLoughlin R
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30759879
[TBL] [Abstract][Full Text] [Related]
2. Effect of nebuliser and patient interface type on fugitive medical aerosol emissions in adult and paediatric patients.
O'Toole C; McGrath JA; Joyce M; O'Sullivan A; Thomas C; Murphy S; MacLoughlin R; Byrne MA
Eur J Pharm Sci; 2023 Aug; 187():106474. PubMed ID: 37225006
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Fugitive Aerosols Released into the Environment during High-Flow Therapy.
McGrath JA; O'Toole C; Bennett G; Joyce M; Byrne MA; MacLoughlin R
Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159408
[TBL] [Abstract][Full Text] [Related]
4. Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control.
Mac Giolla Eain M; Cahill R; MacLoughlin R; Nolan K
Drug Deliv; 2022 Dec; 29(1):10-17. PubMed ID: 34962221
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Various Mitigation Devices in Reducing Fugitive Emissions from Nebulizers.
Harnois LJ; Alolaiwat AA; Jing G; Fink JB; Dhand R; Li J
Respir Care; 2022 Apr; 67(4):394-403. PubMed ID: 34753815
[TBL] [Abstract][Full Text] [Related]
6. An in vitro investigation into the release of fugitive medical aerosols into the environment during manual ventilation.
Mac Giolla Eain M; Joyce M; O'Sullivan A; McGrath JA; MacLoughlin R
J Hosp Infect; 2021 Feb; 108():135-141. PubMed ID: 33296706
[TBL] [Abstract][Full Text] [Related]
7. The Laboratory Characterization of Fugitive Aerosol Emissions From a Standard Jet Nebulizer With and Without a Filtered Mouthpiece.
Dhanak M; Verma S; Hughes PG; Ching AL; Lo A; Clay C; McKinney A; Frankenfield J
Cureus; 2023 Dec; 15(12):e50611. PubMed ID: 38226095
[TBL] [Abstract][Full Text] [Related]
8. Mitigating Fugitive Aerosols During Aerosol Delivery via High-Flow Nasal Cannula Devices.
Li J; A Alolaiwat A; J Harnois L; Fink JB; Dhand R
Respir Care; 2022 Apr; 67(4):404-414. PubMed ID: 34789564
[TBL] [Abstract][Full Text] [Related]
9. [Drug Output and Aerosol Characteristics of Different Jet Nebulisers for Adults While Simulating the Nebulisation of Salbutamol].
Walz-Jung H; Krämer I; Kamin W
Pneumologie; 2018 Dec; 72(12):820-831. PubMed ID: 30453377
[TBL] [Abstract][Full Text] [Related]
10. Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children.
Ari A; de Andrade AD; Sheard M; AlHamad B; Fink JB
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):281-9. PubMed ID: 25493535
[TBL] [Abstract][Full Text] [Related]
11. Impact of different nebulisers' connections on aerosol therapy.
Abdelrahman MA; Abdelrahim ME; Saeed H
Int J Clin Pract; 2021 Oct; 75(10):e14493. PubMed ID: 34117678
[TBL] [Abstract][Full Text] [Related]
12. The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions.
Farkas Á; Tomisa G; Kugler S; Nagy A; Vaskó A; Kis E; Szénási G; Gálffy G; Horváth A
Int J Pharm X; 2023 Dec; 5():100167. PubMed ID: 36824288
[TBL] [Abstract][Full Text] [Related]
13. Fugitive aerosols in the intensive care unit: a narrative review.
O'Toole C; Joyce M; McGrath JA; O'Sullivan A; Byrne MA; MacLoughlin R
Ann Transl Med; 2021 Apr; 9(7):592. PubMed ID: 33987290
[TBL] [Abstract][Full Text] [Related]
14. Aerosol delivery during spontaneous breathing with different types of nebulizers- in vitro/ex vivo models evaluation.
Lin HL; Fang TP; Cho HS; Wan GH; Hsieh MJ; Fink JB
Pulm Pharmacol Ther; 2018 Feb; 48():225-231. PubMed ID: 29277689
[TBL] [Abstract][Full Text] [Related]
15. Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy.
Bennett G; Joyce M; Fernández EF; MacLoughlin R
Intensive Care Med Exp; 2019 Apr; 7(1):20. PubMed ID: 30945044
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen.
Murphy B; Eain MMG; Joyce M; Fink JB; MacLoughlin R
ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36225335
[TBL] [Abstract][Full Text] [Related]
17. Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma.
Ditcham W; Murdzoska J; Zhang G; Roller C; von Hollen D; Nikander K; Devadason SG
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S63-75. PubMed ID: 25054483
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Different Closed Suction Catheter Designs and pMDI Adapters on Aerosol Delivery in Simulated Adult Mechanical Ventilation With and Without Exhaled Humidity.
Williams JP; Ari A; Shanmugam R; Fink JB
Respir Care; 2018 Sep; 63(9):1154-1161. PubMed ID: 29844214
[TBL] [Abstract][Full Text] [Related]
19. Development and application of an aerosol screening model for size-resolved urban aerosols.
Stanier CO; Lee SR;
Res Rep Health Eff Inst; 2014 Jun; (179):3-79. PubMed ID: 25145039
[TBL] [Abstract][Full Text] [Related]
20. The impact of changing patient interfaces on delivering aerosol with titrated oxygen in the high flow system.
Madney YM; Ibrahim Laz N; Elberry AA; Rabea H; Abdelrahim MEA
Int J Clin Pract; 2021 Apr; 75(4):e13898. PubMed ID: 33280194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
